AI-based medical technology company Waysen announced on the 7th that it signed a business agreement (MOU) with Hue Central Hospital, a general hospital in central Vietnam, on July 4th for the clinical use and local expansion of its artificial intelligence (AI) endoscopic solution 'WAYMED Endo'.
This agreement is an extension of the clinical research collaboration related to 'WayMed Endo' that the two organizations have been conducting since the first half of this year, and is focused on establishing a foundation for the practical introduction and expansion of AI endoscopy technology in the Vietnamese medical environment. Currently, both parties are verifying the validity and applicability of the technology in an actual clinical environment.
Hue Central Hospital is a key medical institution under the Ministry of Health of Vietnam, established in 1894, with a total of 5,500 beds. It plays a role in overseeing medical services in the central region of Vietnam and operates an endoscopy center that performs an average of more than 300 endoscopy examinations per day.
The results of clinical studies using 'WayMed Endo' were presented at the Vietnam VGEC 2025 conference in April and the International Society of Gastrointestinal Endoscopy (IDEN 2025) in June, and the clinical effectiveness of the technology garnered attention.
“Considering the importance of endoscopic screening, the introduction of AI technology can be an opportunity to enhance the hospital’s diagnostic capacity,” said Dr. Pham Nhu Hiep, director of Hue Central Hospital.
“Our collaboration with Hue Central Hospital will play a key role in ensuring the clinical reliability of our AI endoscopy technology,” said Weixen CEO Kim Kyung-nam. “We will expand our technology throughout Vietnam in the future to contribute to early diagnosis and improved accessibility to medical care.”
- See more related articles
You must be logged in to post a comment.